Seaport Therapeutics, Inc. (SPTX) Insider Trading
Sector: Pharmaceuticals · Market Cap: $974M · 0 insider purchases in the last 7 days
No open market insider purchases at Seaport Therapeutics, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track SPTX on your watchlist.
Start for FreeAbout Seaport Therapeutics, Inc. Insider Trading
2 insiders at Seaport Therapeutics, Inc. (SPTX) have purchased stock in the past 90 days, totaling $20.0M across 2 transactions (1,113,000 shares).
The most recent purchase was by Director HOMBACH ROBERT J. on June 22, 2026 — a $236K buy of 13,000 shares at $18.14, bringing his total holdings to 13,000 shares.
Insiders who purchased: ARCH Venture Partners XII, LLC (10%+ Owner, 1 buy totaling $19.8M); HOMBACH ROBERT J. (Director, 1 buy totaling $236K).
This insider buying is notable given that SPTX had no recorded open market purchases in the nine months before that.
SPTX is in the Pharmaceuticals sector within the Pharmaceuticals industry with a market cap of $974M.
Track SPTX insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.